Skip to content

Study for the effect of Huatan Quyu prescription in the treatment of the patients with cerebral small vascular disease

Study for the effect of Huatan Quyu prescription in the treatment of the patients with cerebral small vascular disease

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005528
Enrollment
Unknown
Registered
2022-01-11
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular disease

Interventions

Sponsors

Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of cerebral small vascular disease; ? It conforms to the diagnostic criteria of phlegm and blood stasis syndrome of apoplexy; ? = 18 years old =80 years old, no gender limitation; ?3 points =NIHSS score =6 points; ? The patient is conscious, the crude determination of the force, attention, memory and other basic normal, with examination adhere to the treatment; ? The patient or legal representative agrees and signs the informed consent

Exclusion criteria

Exclusion criteria: ? Patients receiving intravenous thrombolysis; ? Magnetic resonance angiography (MRA) showed obvious stenosis or occlusion of intracranial large vessels; ? Unable to complete the examination, such as consciousness impairment, hearing impairment, etc.; (4) suffering from diseases involving central nervous system, such as multiple sclerosis, carbon monoxide poisoning and other causes of white matter abnormalities; (5) Subcortical infarction or watershed infarction, subcortical infarction lesions > 20mm; ? Hereditary small vascular disease, previous history of cerebral hemorrhage or large area of cerebral infarction, atrial fibrillation; ? Patients with severe liver and renal insufficiency (note: Liver dysfunction refers to ALT or AST greater than 2 times the normal upper limit; Renal insufficiency (Cr > 2 times normal upper limit), hematopoietic system, tumor and other serious primary diseases and psychiatric patients. MRI scan contraindications or unable to scan; ? Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
TCM syndrome integral;NIHSS;

Countries

china

Contacts

Public ContactLiu Yanni
yanniliu0828@sina.com13629189825

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026